FDA Shows Deft Touch With 1st Mobile App Enforcement
The U.S. Food and Drug Administration's Tuesday move to rein in a developer of iPhone urinalysis software marked a perfectly balanced foray into stronger oversight of the fledgling mobile medical apps...To view the full article, register now.
Already a subscriber? Click here to view full article